Financhill
Sell
34

FATE Quote, Financials, Valuation and Earnings

Last price:
$0.99
Seasonality move :
30.36%
Day range:
$0.98 - $1.02
52-week range:
$0.66 - $1.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.59x
P/B ratio:
0.49x
Volume:
991.9K
Avg. volume:
1.4M
1-year change:
-38.27%
Market cap:
$115.4M
Revenue:
$13.6M
EPS (TTM):
-$1.32

Fate Therapeutics, Inc. SEC Filings

Company Filed Form Type Description
FATE
Fate Therapeutics, Inc.
05/09/2024 10-Q 10-Q filing on 05/09/2024 View Form
FATE
Fate Therapeutics, Inc.
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
FATE
Fate Therapeutics, Inc.
08/08/2023 10-Q 10-Q filing on 08/08/2023 View Form
FATE
Fate Therapeutics, Inc.
05/03/2023 10-Q 10-Q filing on 05/03/2023 View Form
FATE
Fate Therapeutics, Inc.
11/03/2022 10-Q 10-Q filing on 11/03/2022 View Form
FATE
Fate Therapeutics, Inc.
08/03/2022 10-Q 10-Q filing on 08/03/2022 View Form
FATE
Fate Therapeutics, Inc.
05/04/2022 10-Q 10-Q filing on 05/04/2022 View Form
FATE
Fate Therapeutics, Inc.
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
FATE
Fate Therapeutics, Inc.
08/04/2021 10-Q 10-Q filing on 08/04/2021 View Form
FATE
Fate Therapeutics, Inc.
05/05/2021 10-Q 10-Q filing on 05/05/2021 View Form
FATE
Fate Therapeutics, Inc.
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
FATE
Fate Therapeutics, Inc.
08/05/2020 10-Q 10-Q filing on 08/05/2020 View Form
FATE
Fate Therapeutics, Inc.
05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
FATE
Fate Therapeutics, Inc.
03/02/2020 10-K 10-K filing on 03/02/2020 View Form
FATE
Fate Therapeutics, Inc.
11/05/2019 10-Q 10-Q filing on 11/05/2019 View Form
FATE
Fate Therapeutics, Inc.
08/06/2019 10-Q 10-Q filing on 08/06/2019 View Form
FATE
Fate Therapeutics, Inc.
05/07/2019 10-Q 10-Q filing on 05/07/2019 View Form
FATE
Fate Therapeutics, Inc.
03/05/2019 10-K 10-K filing on 03/05/2019 View Form
FATE
Fate Therapeutics, Inc.
02/08/2019 10-Q 10-Q filing on 02/08/2019 View Form
FATE
Fate Therapeutics, Inc.
11/01/2018 10-Q 10-Q filing on 11/01/2018 View Form
FATE
Fate Therapeutics, Inc.
08/06/2018 10-Q 10-Q filing on 08/06/2018 View Form
FATE
Fate Therapeutics, Inc.
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
FATE
Fate Therapeutics, Inc.
03/05/2018 10-K 10-K filing on 03/05/2018 View Form
FATE
Fate Therapeutics, Inc.
11/01/2017 10-Q 10-Q filing on 11/01/2017 View Form
FATE
Fate Therapeutics, Inc.
08/14/2017 10-Q 10-Q filing on 08/14/2017 View Form
FATE
Fate Therapeutics, Inc.
05/15/2017 10-Q 10-Q filing on 05/15/2017 View Form
FATE
Fate Therapeutics, Inc.
03/16/2017 10-K 10-K filing on 03/16/2017 View Form
FATE
Fate Therapeutics, Inc.
11/07/2016 10-Q 10-Q filing on 11/07/2016 View Form
FATE
Fate Therapeutics, Inc.
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
FATE
Fate Therapeutics, Inc.
05/09/2016 10-Q 10-Q filing on 05/09/2016 View Form
FATE
Fate Therapeutics, Inc.
03/03/2016 10-K 10-K filing on 03/03/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 12.13% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock